Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03345082 |
|---|---|
| Brief Title: | A Dose Ranging Study of OPT-302 With Ranibizumab in Neovascular (Wet) AMD |
| First Submitted : | November 14, 2017 |
| First Submitted that Met QC Criteria : | November 14, 2017 |
| First Posted : | November 17, 2017 |
| Certification/Extension First Submitted : | January 8, 2021 |
| Certification/Extension First Submitted that Met QC Criteria : | January 8, 2021 |
| Certification/Extension First Posted : | January 12, 2021 |
| Last Update Submitted that Met QC Criteria : | January 8, 2021 |
| Last Update Posted : | January 12, 2021 |